Vascular Solutions, Inc. (VASC)
Q4 2013 Earnings Conference Call
February 4, 2014 04:30 p.m. ET
Phil Nalbone – Vice President, Corporate Development
Howard Root – CEO
James Hennen – SVP Finance & CFO
ITGI announces today the initiation of its activity in the
U.S. market. The company has signed a strategic cooperation agreement
with U.S.-based Vascular Solutions, Inc. (NASDAQ: VASC), an international
leader in the...
Vascular Solutions (Nasdaq: VASC) announced today that it has filed a patent infringement complaint in the U.S. District Court for the District of Minnesota against Boston Scientific Corporation (NYSE: BSX). The complaint alleges that Boston...
In a report published Wednesday, Piper Jaffray analyst Thomas J. Gunderson initiated coverage on Vascular Solutions (NASDAQ: VASC) with an Overweight rating and $18.00 price target.
In the report, Gunderson noted, “We are initiating coverage...
In a report published Monday, Canaccord Genuity analyst Jason R. Mills reiterated a Buy rating and $20.50 price target on Vascular Solutions (NASDAQ: VASC).
In the report, Mills noted, “Vascular Solutions announced that it initiated a...
Oops! Unable to complete your request. Please refresh your browser.
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.